STOK Return on Tangible Equity | Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. (STOK) Return on Tangible Equity

2026-06-30: Return Tang Equity -60.17%.
2026-03-31: Return Tang Equity -42.99%.
2025-12-31: Return Tang Equity -1.95%.
2025-09-30: Return Tang Equity 13.17%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-60.17%
2026-03-31	-42.99%
2025-12-31	-1.95%
2025-09-30	13.17%
2025-06-30	15.67%
2025-03-31	14.36%
2024-12-31	-38.85%
2024-09-30	-45.43%
2024-06-30	-42.67%
2024-03-31	-77.33%
2023-12-31	-65.62%
2023-09-30	-59.77%
2023-06-30	-55.19%
2023-03-31	-46.28%
2022-12-31	-54.68%
2022-09-30	-48.92%
2022-06-30	-42.95%
2022-03-31	-39.03%
2021-12-31	-39.40%
2021-09-30	-31.96%
2021-06-30	-26.27%
2021-03-31	-21.29%
2020-12-31	-18.26%
2020-09-30	-24.85%
2020-06-30	-21.02%
2020-03-31	-17.55%
2019-12-31	-14.40%
2019-09-30	-11.32%
2019-06-30	-8.76%
2019-03-31	-16.42%
2018-12-31	-11.92%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-1.95%
2024-12-31	-38.85%
2023-12-31	-65.62%
2022-12-31	-54.68%
2021-12-31	-39.40%
2020-12-31	-18.26%
2019-12-31	-14.40%
2018-12-31	-11.92%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Xencor Inc (XNCR)	United States	$1.776B	-7.33
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01